NeuroPace Newsroom

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Futu NewsDec 6 00:31

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 22 20:31

NeuroPace Is Maintained at Overweight by Wells Fargo

Dow JonesNov 14 01:29

NeuroPace Analyst Ratings

BenzingaNov 14 01:20

Morgan Stanley Maintains NeuroPace(NPCE.US) With Hold Rating, Maintains Target Price $8

Futu NewsNov 13 21:36

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Cuts Target Price to $13

Futu NewsNov 13 19:31

NeuroPace's Strong Financial Performance and Strategic Advancements Justify Buy Rating

TipRanksNov 13 18:43

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 12 22:35

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 11 22:31

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Futu NewsSep 5 21:31

NeuroPace (NPCE) Gets a Buy From Lake Street

TipRanksSep 5 20:49

A Quick Look at Today's Ratings for NeuroPace(NPCE.US), With a Forecast Between $8 to $20

Futu NewsAug 15 21:02

Cantor Fitzgerald Reiterates Overweight on NeuroPace, Maintains $18 Price Target

BenzingaAug 14 21:47

NeuroPace Analyst Ratings

BenzingaAug 14 21:29

Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Cuts Target Price to $15

Futu NewsAug 14 19:34

Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20

Futu NewsAug 13 21:33

NeuroPace Analyst Ratings

BenzingaJul 16 00:58

Morgan Stanley Lowers Price Target on NeuroPace to $8 From $9.50, Keeps Equalweight Rating

MT NewswiresJul 15 19:13

Strong Sales Growth and Strategic Initiatives Justify Buy Rating for NeuroPace

TipRanksMay 29 17:51

Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating

MT NewswiresMay 13 18:54